Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients

Neuroscience Letters

Volumn 239, Issue 1, 1997, Pages 29-32

  März, Pia ^a   Heese, Klaus ^b   Hock, Christoph ^b   Golombowski, Sidonie ^b   Müller Spahn, Franz ^b   Rose John, Stefan ^a   Otten, Uwe ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cytokines; Enzyme linked immunosorbent assay; Inflammation; Neurodegeneration; Neurotrophins

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NEUROTROPHIN;

ACUTE PHASE RESPONSE; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MODELS, MOLECULAR; RECEPTORS, INTERLEUKIN-6; SOLUBILITY;

EID: 0344333426     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00886-0     Document Type: Article

References (22)

1. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., Berger M. Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
2. Blum-Degen D., Müller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202:1995;17-20.
3. Brugg B., Dubreuil Y.L., Huber G., Wollmann E.E., Delhayebouchaud N., Mariani J. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. USA. 92:1995;3032-3035.
4. Ehlers M., Grötzinger J., DeHon F.D., Müllberg J., Brakenhoff J.P.J., Liu J., Wollmer A., Rose-John S. Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. J. Immunol. 153:1994;1744-1753.
5. Folstein M.F., Folstein S.E., McHugh P.R. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 12:1975;189-198.
6. Frieling J.T., Sauerwein R.W., Wijdenes J., Van der Linden C.J. Soluble interleukin-6 receptor in biological fluids from human origin. Cytokine. 6:1994;376-381.
7. Hampel H., Schoen D., Schwarz M.J., Kötter H.U., Schneider C., Sunderland T., Dukoff R., Levy J., Padberg F., Stübner S., Buch K., Müller N., Möller H.-J. Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Neurosci. Lett. 228:1997;143-146.
8. Honda M., Yamamoto S., Cheng M., Yasukawa K., Suzuki H., Saito T., Osugi Y., Tokunaga T., Kishimoto T. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148:1992;2175-2180.
9. Hüll M., Strauss S., Berger M., Volk B., Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav. Brain Res. 78:1996;37-41.
10. Hüll M., Strauss S., Volk B., Berger M., Bauer J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. 89:1995;544-551.
11. Krüttgen A., Rose-John S., Dufhues G., Bender S., Lütticken C., Freyer P., Heinrich P.C. The three carboxy-terminal amino acids of human interleukin-6 are essential for its biological activity. FEBS Lett. 273:1990;95-98.
12. März, P., Cheng, J.-G., Gadient, R.A., Patterson, P.H., Stoyan, T., Otten, U. and Rose-John, S., Sympathetic neurons can produce and respond to interleukin-6, Proc. Natl. Acad. Sci. USA, submitted.
13. McGeer P.L., McGeer E.G. The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
14. McKhann G., Drachman D., Folstein M., Katzmann R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1997;939-944.
15. Narazaki M., Yasukawa K., Novick D., Engelmann D., Wallach D., Rubinstein M. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170:1989;1409-1414.
16. Paonessa G., Graziani R., De Serio A., Savino R., Ciapponi R., Lahm A., Salvati A.L., Toniatti C., Ciliberto C. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO J. 14:1995;1942-1951.
17. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300:1994;281-290.
18. Saito T., Ohsugi Y., Fukui H., Koishihara Y., Yancopoulos G.D., Taga T., Kishimoto T. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 82:1993;1120-1126.
19. Savino R., Lahm A., Salvati A.L., Ciapponi L., Sporeno E., Altamura S., Paonessa G., Toniatti C., Ciliberto G. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 13:1994;1357-1367.
20. Wood J.A., Wood P.L., Ryan R., Graff-Radford N.R., Pilapil C., Robitaille Y., Quirion R. Cytokines indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. Brain Res. 629:1993;245-252.
21. Yamada K., Kono K., Umegaki H., Yamada K., Iguchi A., Fukatsu T., Nakashima N., Nishiwaki H., Shimada Y., Sugita Y., Yamamoto T., Hasegawa T., Nabeshima T. Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci. Lett. 186:1995;219-221.
22. Zohlenhöfer D., Graeve L., Rose-John S., Schooltink H., Dittrich E., Heinrich P.C. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett. 306:1992;219-222.